These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22252236)

  • 1. Preserved acetazolamide reactivity in lacunar patients with severe white-matter lesions: 15O-labeled gas and H2O positron emission tomography studies.
    Nezu T; Yokota C; Uehara T; Yamauchi M; Fukushima K; Toyoda K; Matsumoto M; Iida H; Minematsu K
    J Cereb Blood Flow Metab; 2012 May; 32(5):844-50. PubMed ID: 22252236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of cerebrovascular reserve in acetazolamide challenge -comparison with acetazolamide challenge H2O-PET and Gas-PET.
    Imaizumi M; Kitagawa K; Oku N; Hashikawa K; Takasawa M; Yoshikawa T; Osaki Y; Matsushita K; Matsumoto M; Hori M; Hatazawa J
    Ann Nucl Med; 2004 Jul; 18(5):369-74. PubMed ID: 15462398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between cerebral circulatory reserve and oxygen extraction fraction in patients with major cerebral artery occlusive disease: a positron emission tomography study.
    Yata K; Suzuki A; Hatazawa J; Shimosegawa E; Nagata K; Sato M; Moroi J
    Stroke; 2006 Feb; 37(2):534-6. PubMed ID: 16410481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain arteriolosclerosis and hemodynamic disturbance may induce leukoaraiosis.
    Yamauchi H; Fukuyama H; Nagahama Y; Shiozaki T; Nishizawa S; Konishi J; Shio H; Kimura J
    Neurology; 1999 Nov; 53(8):1833-8. PubMed ID: 10563635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcortical hypoperfusion associated with asymptomatic white matter lesions on magnetic resonance imaging.
    Hatazawa J; Shimosegawa E; Satoh T; Toyoshima H; Okudera T
    Stroke; 1997 Oct; 28(10):1944-7. PubMed ID: 9341700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases.
    Kuroda S; Shiga T; Ishikawa T; Houkin K; Narita T; Katoh C; Tamaki N; Iwasaki Y
    J Nucl Med; 2004 Jun; 45(6):943-9. PubMed ID: 15181128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral blood flow and metabolism associated with cerebral microbleeds in small vessel disease.
    Hashimoto T; Yokota C; Koshino K; Shimomura R; Hino T; Moriguchi T; Hori Y; Uehara T; Minematsu K; Iida H; Toyoda K
    Ann Nucl Med; 2016 Aug; 30(7):494-500. PubMed ID: 27246951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetazolamide reactivity on 123I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: correlation with positron emission tomography parameters.
    Hirano T; Minematsu K; Hasegawa Y; Tanaka Y; Hayashida K; Yamaguchi T
    J Cereb Blood Flow Metab; 1994 Sep; 14(5):763-70. PubMed ID: 8063872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET evaluation of cerebral hemodynamics in occlusive cerebrovascular disease pre- and postsurgery.
    Kuwabara Y; Ichiya Y; Sasaki M; Yoshida T; Fukumura T; Masuda K; Fujii K; Fukui M
    J Nucl Med; 1998 May; 39(5):760-5. PubMed ID: 9591570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.
    Okazawa H; Yamauchi H; Sugimoto K; Takahashi M
    J Nucl Med; 2003 Sep; 44(9):1371-8. PubMed ID: 12960179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reduction of regional cerebral blood flow in normal-appearing white matter is associated with the severity of white matter lesions in elderly: a Xeon-CT study.
    Fu J; Tang J; Han J; Hong Z
    PLoS One; 2014; 9(11):e112832. PubMed ID: 25401786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of central benzodiazepine receptor binding potential/cerebral blood flow SPECT imaging for detecting misery perfusion in patients with unilateral major cerebral artery occlusive diseases: comparison with cerebrovascular reactivity to acetazolamide and cerebral blood flow SPECT imaging.
    Kuroda H; Ogasawara K; Suzuki T; Chida K; Aso K; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Kubo Y; Ogawa A
    Clin Nucl Med; 2012 Mar; 37(3):235-40. PubMed ID: 22310248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative evaluation of cerebral blood flow and oxygen metabolism in normal anesthetized rats: 15O-labeled gas inhalation PET with MRI Fusion.
    Watabe T; Shimosegawa E; Watabe H; Kanai Y; Hanaoka K; Ueguchi T; Isohashi K; Kato H; Tatsumi M; Hatazawa J
    J Nucl Med; 2013 Feb; 54(2):283-90. PubMed ID: 23287575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central benzodiazepine receptor binding potential and CBF images on SPECT correlate with oxygen extraction fraction images on PET in the cerebral cortex with unilateral major cerebral artery occlusive disease.
    Chida K; Ogasawara K; Kuroda H; Aso K; Kobayashi M; Fujiwara S; Yoshida K; Terasaki K; Ogawa A
    J Nucl Med; 2011 Apr; 52(4):511-8. PubMed ID: 21421729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of
    Hashimoto T; Yokota C; Koshino K; Temma T; Yamazaki M; Iguchi S; Shimomura R; Uehara T; Funatsu N; Hino T; Minematsu K; Iida H; Toyoda K
    Ann Nucl Med; 2017 Apr; 31(3):227-234. PubMed ID: 28220365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constant-infusion H(2)15O PET and acetazolamide challenge in the assessment of cerebral perfusion status.
    Weber B; Westera G; Treyer V; Burger C; Khan N; Buck A
    J Nucl Med; 2004 Aug; 45(8):1344-50. PubMed ID: 15299060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Day-to-day test-retest variability of CBF, CMRO2, and OEF measurements using dynamic 15O PET studies.
    Bremmer JP; van Berckel BN; Persoon S; Kappelle LJ; Lammertsma AA; Kloet R; Luurtsema G; Rijbroek A; Klijn CJ; Boellaard R
    Mol Imaging Biol; 2011 Aug; 13(4):759-68. PubMed ID: 20700768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
    Okazawa H; Yamauchi H; Toyoda H; Sugimoto K; Fujibayashi Y; Yonekura Y
    J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Database of normal human cerebral blood flow, cerebral blood volume, cerebral oxygen extraction fraction and cerebral metabolic rate of oxygen measured by positron emission tomography with 15O-labelled carbon dioxide or water, carbon monoxide and oxygen: a multicentre study in Japan.
    Ito H; Kanno I; Kato C; Sasaki T; Ishii K; Ouchi Y; Iida A; Okazawa H; Hayashida K; Tsuyuguchi N; Ishii K; Kuwabara Y; Senda M
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):635-43. PubMed ID: 14730405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic changes during neural deactivation in human brain: a positron emission tomography study of crossed cerebellar diaschisis.
    Ito H; Kanno I; Shimosegawa E; Tamura H; Okane K; Hatazawa J
    Ann Nucl Med; 2002 Jun; 16(4):249-54. PubMed ID: 12126094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.